Big Pharma Strikes Megadeals In Targeted Protein Degradation
With many targeted protein degraders hitting the clinic, lucrative collaborations and acquisitions are being signed…
12/11/2021 - 5 minutes
Bayer
Farxiga’s Approval Fuels Chronic Kidney Disease Comeback
Until this year, there were no effective treatments for chronic kidney disease. However, the recent…
08/06/2021 - 5 minutes
Women’s Health Gains Traction as Bayer Pays €736M for UK Firm
Bayer’s recent €736M ($875M) acquisition of KaNDy Therapeutics could herald growing investor interest in women’s…
18/08/2020 - 3 minutes
Meiogenix, Bayer Team Up to Boost Genetic Diversity in Crop Breeding
Bayer and the French biotech company Meiogenix will work together to advance the development of…
10/02/2020 - 3 minutes
Bayer Launches Israeli Company to Develop Viruses Against Crop Disease
Bayer is backing the launch of the Israeli biotech Ecophage, which will develop environmentally friendly…
11/07/2019 - 2 minutes
The Race to Get CRISPR to the Clinic: Hope Versus Hype
In 2016, German pharma giant Bayer took a bold step and decided to partner with…
28/06/2018 - 7 minutes
“Have the guts to follow your instincts”: Top CEO Talks About His Time in Biotech
Some careers take on an international scope and span the breadth of big players in…
20/06/2018 - 9 minutes
After settling lawsuit with Bayer, Cellectis spin-off launches €41M follow-on offering
Cellectis spin-off Calyxt has launched a €41M follow-on round after settling the lawsuit it recently brought against Bayer…
17/05/2018 - 2 minutes
CRISPR/Cas9: Could the Gene Editing Technology be the Future of Drug Discovery?
The emergence of CRISPR/Cas9 technologies has enabled almost unlimited gene editing opportunities. Not only could…
06/02/2018 - 9 minutes
Bayer Launches Plant Microbiome Biotech with a Huge €84M Series A
Bayer and Ginkgo Bioworks are launching a new company that will develop new technologies for…
15/09/2017 - 2 minutes
Bayer and Evotec Extend their Endometriosis Partnership
Bayer and Evotec have decided to extend their partnership for the development of endometriosis drugs…
24/07/2017 - 1 minute
Novartis Tops Ophthalmology Blockbuster Eylea in Phase III Trials
Bayer's and Regeneron's blockbuster Eylea could be facing serious competition, as Novartis boasts with positive…
20/06/2017 - 2 minutes
